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Abstract
Congenital infection of the central nervous system by human cytomegalovirus (HCMV) is a leading cause of per-
manent sequelae, including mental retardation or neurodevelopmental abnormalities. The most severe complica-
tions include smooth brain or polymicrogyria, which are both indicative of abnormal migration of neural cells,
although the underlying mechanisms remain to be determined. To gain better insight on the pathogenesis of such
sequelae, we assessed the expression levels of a set of neurogenesis-related genes, using HCMV-infected human
neural stem cells derived from embryonic stem cells (NSCs). Among the 84 genes tested, we found dramatically
increased expression of the gene PAFAH1B1, encoding LIS1 (lissencephaly-1), in HCMV-infected versus unin-
fected NSCs. Consistent with these findings, western blotting and immunofluorescence analyses confirmed the
increased levels of LIS1 in HCMV-infected NSCs at the protein level. We next assessed the migratory abilities
of HCMV-infected NSCs and observed that infection strongly impaired the migration of NSCs, without detectable
effect on their proliferation. Moreover, we observed increased immunostaining for LIS1 in brains of congenitally
infected fetuses, but not in control samples, highlighting the clinical relevance of our findings. Of note,
PAFAH1B1 mutations (resulting in either haploinsufficiency or gain of function) are primary causes of hereditary
neurodevelopmental diseases. Notably, mutations resulting in PAFAH1B1 haploinsufficiency cause classic lissen-
cephaly. Taken together, our findings suggest that PAFAH1B1 is a critical target of HCMV infection. They also
shine a new light on the pathophysiological basis of the neurological outcomes of congenital HCMV infection,
by suggesting that defective neural cell migration might contribute to the pathogenesis of the neurodevelopmental
sequelae of infection.
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Introduction
Human cytomegalovirus (HCMV) is a beta herpesvirus
with a worldwide distribution and an estimated global
seroprevalence of 83% in the general population [1].
Congenital HCMV infection of the central nervous sys-
tem is a leading cause of permanent sequelae (0.1–0.2%
of all live births) [2].
More specifically, 10% of congenitally infected
newborns are symptomatic at birth [2]. Most of them
(60–90%) and 10–15% of those with asymptomatic
infection develop one or more long-term neurological
sequelae, such as mental retardation, psychomotor retar-
dation, sensorineural hearing or vision loss, or cerebral
palsies [2,3].The most severely affected cases show
brain development abnormalities such as lissencephaly
or polymicrogyria [3]. A retrospective review reported
that 10 out of 15 (66%) infants congenitally infected
by HCMV showed polymicrogyria or abnormal gyral
patterns [3,4]. Lissencephalic brains are characterised
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by a smooth surface, whereas excessive abundance of
gyri is found in polymicrogyria. These features are indic-
ative of abnormal migration of neural cells (reviewed in
refs 5 and 6), as observed in hereditary lissencephalies.
Hereditary lissencephalies are monogenic disorders that
show considerable clinical, genetic, and allelic heteroge-
neity, but which, however, are all characterised by defec-
tive neuronal migration during development [7]. Indeed,
the sequential and finely synchronised migration of neu-
ral progenitors, radial glia cells, and neurons are all crit-
ical events for proper brain development [5,6].
Direct infection of neural progenitor cells by HCMV
in the developing brain plausibly contributes to the neu-
rological sequelae due to HCMV congenital infection
[8–11]. In particular, HCMV infection of neural progen-
itors was found to perturb their self-renewal and polarisa-
tion [12], apoptosis [13], or differentiation [8,10,12–14].
To date, however, no evidence has been reported show-
ing that HCMV infection indeed affects neural cell
migration in the developing brain [15].
In this study, we assessed the abnormally expressed
genes in HCMV-infected human neural stem cells derived
from embryonic stem cells (NSCs) and found that infec-
tion causes abnormal expression of PAFAH1B1, the prin-
cipal causative gene for hereditary lissencephalies.
Materials and methods
Ethics statement
Use of NSCs was approved by the French regulatory
authorities (Agence de la Biomédecine, # SASB092
0178S). Collection of brain histological samples was coor-
dinated by Necker Hospital, AP-HP (Assistance Publique
– Hôpitaux de Paris, Agence de la Biomédecine, # PFS-
15009). Written informed consent was obtained from all
study participants prior to sample collection. All samples
were anonymised.
Cells, viruses, and reagents
NSCs, human immortalised fibroblast MRC-5 cells, and
human invasive proliferative extravillous cytotropho-
blast (HIPEC) cells were grown in vitro as detailed else-
where [11,16]. In brief, NSCs were seeded at 100 000
cells/cm2 and maintained in growth medium consisting
of DMEM/F12/Neurobasal medium (Life Technologies,
Carlsbad, CA, USA) mixed at a ratio of 1/1/2 (v/v/v) in
the presence of N2 and B27 supplements (Life Technol-
ogies), FGF2 (10 ng/ml), EGF (10 ng/ml), and BDNF
(20 ng/ml), all from Peprotech, Rocky Hill, NJ, USA.
Culture supports were first coated using 0.05% poly-
ornithine (PO) (Sigma, St Louis, MO, USA), followed
by mouse laminin (1 μg/cm2) (Roche, Basel, Switzer-
land), both diluted in PBS. NSC cultures were checked
for the absence of mycoplasma (Plasmotest; Invivogen,
Toulouse, France). The MRC-5 line (CCL171; ATCC,
Manassas, VA, USA) was cultured in DMEM contain-
ing 10% bovine calf serum (Life Technologies). The
HIPEC line (a gift from T Fournier, INSERM UMR-
S1139, Paris Descartes University, Paris, France) was
cultured in DMEM/F12 (1/1), supplemented with 10%
bovine calf serum.
Weused theVHL/EHCMVstrain (a gift fromCSinzger,
Ulm, Germany) at low passage (<8) of amplification in
MRC-5 cells and the AD169 HCMV strain (ATCC
VR538). Preparation and titration of viral stocks and UV
irradiation of viral inoculums were as detailed elsewhere
[11]. Titration of viral suspensions was performed by
immunofluorescence analysis on MRC-5 cells 24 h post-
infection, using an antibody against HCMV immediate-
early antigen (IE). We used primary antibodies specific
to IE (mouse monoclonal; bioMérieux, Marcy l’Etoile,
France), LIS1 (rabbit polyclonal, ab2607; Abcam, Cam-
bridge, UK), DCX (rabbit polyclonal, ab18723; Abcam),
Ki-67 (rabbit monoclonal; Merck Life Science, Dorset,
UK), and alpha-tubulin (rabbit monoclonal, 11H10; Cell
Signaling Technology, Leiden, TheNetherlands). Second-
ary antibodies were conjugated either with horseradish
peroxidase (Promega, Madison, WI, USA) for western-
blot assays and immunohistochemistry (IHC) or with
Alexa-488, -555 or -633 fluorophores (Life Technolo-
gies) for immunofluorescence analyses.
mRNA analysis
NSCs were infected at a multiplicity of infection (MOI)
of 10 using the AD169 or VHL/E strains or left unin-
fected and harvested 72 h post-infection (pi). Total
RNA was extracted from actively growing NSCs (i.e. at
approximately 75% confluency) using Trizol (Life Tech-
nologies) according to the supplier’s recommendations.
Ten micrograms of RNA was reverse-transcribed in the
presence of oligo-dT using Superscript III reverse tran-
scriptase (Life Technologies). A first screen was per-
formed using the RT2 Profiler Neurogenesis kit
(Qiagen, Hilden, Germany) according to the supplier’s
recommendations. Next, quantitative real-time PCR
(qPCR) assays were performed as devised elsewhere
[11] using Takyon qPCR mastermix (Eurogentec, Liège,
Belgium), oligonucleotide probes (Qiagen) specific to
PAFAH1B1 and RPLP0 (ribosomal protein, large, P0),
as a reference gene, and an LC480 system (Roche). For
each experiment, two batches of NSCswere infected sep-
arately. For each, RT-qPCR was duplicated. Culture pas-
sage was between 10 and 12.
Western blotting
NSCs were infected at an MOI of 10, or left uninfected,
and harvested 72 h pi. Cell extract preparations and west-
ern blotting analyseswere performed as detailed elsewhere
[11]. Detection was carried out using a chemilumines-
cence kit (Sigma). Analyses were performed with a
Chemidoc system (Bio-Rad, Hercules, CA, USA). Densi-
tometry analyses were performed using ImageJ soft-
ware [17].
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Immunofluorescence
Cells were cultured on coverslips, fixed in 4% formalde-
hyde for 20 min at 4 C, and permeabilised in 0.3% Tri-
ton X-100 for 15 min at room temperature. Blocking
buffer was PBS containing 5% FCS. Primary antibodies
diluted in blocking buffer were applied overnight at
4 C. Antibodies to IE, LIS1, DCX, Ki-67, and alpha-
tubulin were diluted 500-, 250-, 250-, 100-, and
50-fold, respectively. Secondary antibodies diluted in
blocking buffer were applied for 1 h at room tempera-
ture. After three washes with blocking buffer and three
washes with PBS, cells were counterstained with
1 μg/ml DAPI (Sigma) and washed again three times
with PBS before mounting the coverslips onto glass
slides. Examination was performed using an LSM
710 confocal microscope (Zeiss, Oberkochen, Ger-
many). Image processing was performed using either
ImageJ (maximal-intensity projections, measurements
of length) or Imaris (Oxford Instruments, Abingdon,
UK) (3D reconstructions). The relative number of Ki-
67-positive cells was assessed by manual counting from
captures of five visual fields, each containing 100–200
cells.
Cell migration assays
Cell migration assays were performed using the Oris
Cell Migration Assay (Platypus Technologies, Madison,
WI, USA) according to the supplier’s recommendations.
NSCs were plated in dedicated 96-well plates at a den-
sity of 50 000 cells per well, in the presence of silicone
stoppers at the centre of each well, to generate a cell-free
exclusion zone. The next day, NSCs were infected by
HCMV; then the culture medium was replaced with
fresh medium containing laminin (1 μg/cm2) and the
stoppers were removed, allowing for NSCs to colonise
the exclusion zone. Brightfield pictures of each well
were taken each day thereafter over 4 days, using an
Apotome Axio-observer microscope (Zeiss). The area
of the remaining cell-free zone was measured using Ima-
geJ software. The growth rate of control or HCMV-
infected NSC cultures was also assessed in parallel
experiments through DAPI staining and counting of
the nuclei over time, by using an automated ArrayScan
microscopy device (Cellomics, Thermo Fisher Scien-
tific, Waltham, MA, USA).
PAFAH1B1 silencing
NSCs were seeded at a density of 60 000 per cm2 in
24-well plates. HIPEC cells were seeded at a density of
25 000 per cm2 in 24-well plates. The day after, fresh
medium containing 100 pmol of non-targeting- or
LIS1-siRNAs was added to each well according to the
supplier’s recommendations (Horizon Discovery, Cam-
bridge, UK) and 24 h later, cells were infected at an
MOI of 10 or left uninfected. Immunofluorescence anal-
ysis was next performed at 4, 24, and 72 h pi. To assess
cell death, cells were incubated for 30 min at 37 C in
growth medium supplemented with the Image-iT™
DEAD reagent (Life Technologies) at a final concentra-
tion of 100 nM, before carrying out immunofluorescence
assays as detailed above.
Immunohistochemical analyses
Brain tissue biopsies were collected from four human
fetuses electively aborted because of HCMV infection
and from two controls aborted for Di George syndrome
with associated cardiopathy (control case 1200496) or
for premature rupture of membranes, anamnios, and
chorioamnionitis (control case 1200094). Immunohisto-
chemical brain analysis of controls and HCMV cases
was performed on sections cut at 8 μm from paraffin
blocks, using standard methods. Antigen was retrieved
through two consecutive incubations (11 and 10 min)
in a microwave oven for DCX or one 40-min incubation
at 95 C in a heating bath for LIS1. Endogenous perox-
idase activity and biotin were blocked by using the
avidin–biotin and peroxidase blocking reagents (Vector
Labs, Burlingame, CA, USA) for 10 min at room tem-
perature. Primary antibodies were diluted 800-fold
(DCX) or 250-fold (LIS1) in blocking buffer (3% BSA
in PBS). Antibody specificity was ascertained by parallel
staining experiments using either no primary antibody or
a non-specific isotype control.
Staining for LIS1, DCX, and Mayer’s haematoxylin
counterstain was performed using an Autostainer device
(Dako, Glostrup, Denmark), and resulting slides were
scanned using a Panoramic 250 system (3D Histech,
Budapest, Hungary) and analysed with the dedicated
software (3D Histech).
Statistical analysis
Statistical analyses were performed using the StatEL
plugin (Adscience SARL, Paris, France) for Excel
(Microsoft, Redmond, WA, USA), using the Kruskal–
Wallis test. Unless otherwise specified, error bars show
5% confidence intervals (CIs).
Results
In the search for genes with altered expression in
HCMV-infected NSCs, we performed mRNA analysis
using a dedicated array allowing us to analyse a set of
84 genes related to neurogenesis. We used an MOI of
10 with respect to titration in MRC-5 cells, a condition
that led to approximately 30–40% of NSCs displaying
positive IE immunostaining 72 h post-infection. We
reported previously that infection at this MOI does not
result in any increased apoptosis [11]. Most of the genes
of this array showed only minor changes in transcript
levels upon HCMV infection (supplementary material,
Table S1). Yet we found that the steady-state levels of
mRNA of the genes ACHE, APOE, S100A6, and
PAFAH1B1 were increased by 3.68-, 4.65-, 5.73-, and
56.67-fold, respectively, in infected NSCs compared
with uninfected control cells (Figure 1A). We focused
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on PAFAH1B1 because this gene is the principal causa-
tive gene of lissencephalies (as reviewed in refs 7 and
18) and because lissencephalic brain is frequently
reported in severe congenital HCMV infection. There-
fore, we next carried out RT-qPCR to validate the result
of the first screen, using mRNA extracted from NSCs
infected by two different HCMV strains, AD169 and
VHL/E. Consistent with the array results, we found that
the steady-state levels of PAFAH1B1 mRNA were
increased 37.67- and 41.32-fold in NSCs infected by
AD169 or VHL/E, respectively, compared with the
uninfected controls (Figure 1A). Notably, no significant
change in the PAFAH1B1mRNA levels was detected in
NSCs treated by UV-irradiated viral particles of the two
strains.
This prompted us to investigate the levels of the pro-
tein encoded by PAFAH1B1, namely LIS1, in NSCs.
In uninfected NSCs, western blotting revealed the
expression of only minute amounts of LIS1 (45 kDa)
(Figure 1B) and no detectable LIS1 was observed by
immunofluorescence analysis (Figure 1C, top row). In
contrast, both western blotting and immunofluorescence
revealed a dramatic increase of LIS1 protein levels in
HCMV-infected NSCs, compared with uninfected con-
trol cells or with NSCs exposed to a UV-irradiated viral
inoculum (Figure 1B,C). Interestingly, immunostaining
for HCMV immediate-early antigen (IE) revealed that
increased staining for LIS1 was only observed in
infected NSCs and not in their neighbouring uninfected
counterparts (Figure 1C,D). Further examination of
infected cells at higher magnification or with 3D recon-
structions revealed dot-like cytoplasmic LIS1 immunos-
taining, distributed as linearly arranged foci, indicative
of cytoskeletal association (Figure 1D and supplemen-
tary material, Movies S1–S4). In most infected cells, a
greater density of fluorescence spots was observed in
the perinuclear zone.
LIS1 is an atypical microtubule-associated protein
[19,20]. To gain insight into the impact of HCMV infec-
tion on the microtubule network of NSCs, we carried out
immunofluorescence analysis of tubulin in infected
NSCs. We detected no difference in the shape of the
microtubule network in infected NSCs compared with
the controls (supplementary material, Figure S1). This
suggested that microtubules were not impacted by infec-
tion at a detectable level in cultured NSCs and that the
pattern of LIS1 staining in infected NSCs is not the con-
sequence of a disrupted microtubule network.
We next investigated the consequence of infection by
HCMV on PAFAH1B1 expression in human fetal lung
MRC-5 fibroblasts. mRNA RT2 profiling (supplemen-
tary material, Table S2) and immunofluorescence analy-
sis (supplementary material, Figure S2) showed that
PAFAH1B1 mRNA levels and LIS1 immunostaining
were increased 8.5-fold in infected MRC-5 cells com-
pared with uninfected MRC-5. Hence, increased LIS1
expression upon HCMV infection did not seem to be
specific to NSCs.
Because poly(micro)gyria and lissencephaly are con-
sidered as neural cell migration disorders [5,6,21], we
investigated possible changes in the migratory capacities
of NSCs upon infection by HCMV. Towards this aim,
we used the Oris cell migration assay, allowing reliable
assessment of the ability of infected or control NSCs to
fill an exclusion zone created by a silicone stopper pre-
sent in the centre of the well during seeding and removed
after infection. We observed that infected NSC cultures
were unable to efficiently colonise the exclusion zone
after 4 days, a stage when their uninfected counterparts
had almost filled the whole area (Figure 2A,B). This
migration deficit of infected cells was not due to cell
lysis, since 4 days is an insufficient timescale for the
completion of a full HCMV lytic cycle in NSCs, as
shown previously [11]. To ensure that this effect was
not the consequence of defective cell proliferation upon
infection, we assessed the growth rates of infected and
control NSCs over time and found no significant differ-
ences (Figure 2C). It has been shown that HCMV infec-
tion can have variable outcomes on the cell cycle, by
either blocking or supporting proliferation [15,22,23].
Therefore, we carried out immunofluorescence analysis
of the Ki-67 proliferation marker using HCMV-infected
NSCs. We found no significant difference in the abun-
dancy of Ki-67+ cells between uninfected cultures, cul-
tures infected by the strain AD169 or by the strain
VHL/E, or cultures treated with irradiated VHL/E viral
particles (supplementary material, Figure S3). Impor-
tantly, we detected many double-positive IE+, Ki-67+
cells among NSCs infected by the VHL/E or the
AD169 strain, indicating that infected NSCs were still
able to undergo the cell cycle. Therefore, the results of
the migration assays most likely revealed impaired
mobility of HCMV-infected NSCs. NSCs treated with
a UV-irradiated viral inoculum showed no differences
with the controls, indicating that only replication-
competent HCMV was able to disrupt NSC mobility.
Taken together, these findings show that HCMV infec-
tion impairs the migration of NSCs in vitro. Next, we
investigated whether counteracting LIS1 overexpression
would restore the migratory capacity of HCMV-infected
NSCs. To this aim, we treated NSC cultures with either
siRNAs specific to LIS1 or non-targeting control siR-
NAs. The two siRNAs shared identical chemistry and
formulation. According to the supplier, a 72-h delay is
required to achieve a good efficacy of silencing;
therefore we started with siRNA treatment and then
inoculated the cultures with HCMV. We observed a
drastically different outcome for the survival of infected
NSCs upon treatment with either LIS1- or control siR-
NAs. Indeed, we observed dramatic levels of cell death
in HCMV-infected NSCs when they were exposed to
the LIS1 siRNA, as evidenced by the positive staining
with the Image-iT™ DEAD reagent, which only enters
into dying cells (supplementary material, Figure S5).
Cell death was so massive that it could be only evi-
denced at 4 h pi and cells were completely lost thereaf-
ter. In contrast, treatment with the non-targeting siRNA
did not result in a detectable effect on cell survival. Inter-
estingly, there was no impact on the survival of
uninfected NSCs upon exposure to either LIS1- or
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Figure 1 Legend on next page.
96 M Rolland et al
© 2021 The Pathological Society of Great Britain and Ireland.
Published by John Wiley & Sons, Ltd. www.pathsoc.org
J Pathol 2021; 254: 92–102
www.thejournalofpathology.com
non-targeting siRNAs. To follow up this observation
and assess its specificity, we investigated the outcomes
of LIS1 siRNA treatment using another HCMV-
permissive cell line of non-neuronal origin, namely the
cytotrophoblast cell line HIPEC. Interestingly, HIPEC
cells do not show detectable expression of LIS1, should
they be infected or not. In this case, we did not observe
any effect of LIS1 siRNA on the survival of HCMV-
infected HIPEC cells (supplementary material,
Figure S5). This result ruled out the possibility of a direct
cytotoxic effect of the LIS1 siRNA solution. Taken
together, our results suggest that LIS1 overexpression
is critical for the survival of HCMV-infected NSCs.
To assess the clinical relevance of our findings con-
cerning LIS1 upregulation upon infection, we next
explored LIS1 levels in histological sections of brain
from congenitally HCMV-infected fetuses (n = 4) com-
pared with control samples (n = 2) with a matching
Figure 1. Enhanced PAFAH1B1/LIS1 expression in HCMV-infected human neural stem cells. (A) RT-qPCR analysis showing dramatically
increased levels of PAFAH1B1 transcripts in HCMV-infected NSCs (MOI 10) at 72 h post-infection (pi). Left: RT2 profiler analysis. The fold-
change values of relative mRNA levels for each gene, compared with that from uninfected NSCs, are shown. Means  CI of three independent
experiments, two replicates per condition. Right: RT-qPCR analysis of PAFAH1B1 mRNA levels in NSCs infected by HCMV strains AD169
(AD169) or VHL/E (VHL/E) (live, black boxes), or with UV-irradiated AD169 or VHL/E (UV, white boxes). Fold-change values of PAFAH1B1mRNA
levels, compared with that from uninfected NSCs. Means  CI of two independent experiments, two replicates per condition.
(B) Representative western blot (top) and densitometry analysis (bottom) of three independent western blotting analyses of LIS1 levels in
HCMV-infected (AD169 strain, MOI 10) NSCs (HCMV) compared with uninfected controls (NI) or with NSCs exposed to UV-irradiated HCMV
(HCMV-UV) at 72 h pi. Error bars show SD. For densitometry analysis, data were normalised to actin levels and are expressed as relative den-
sitometry units (DU), compared with uninfected cells arbitrarily set to 1. (C) Immunofluorescence analysis using antibodies specific to LIS1
(red) or IE (green) showing strong LIS1 immunostaining in NSCs infected by HCMV strain AD169 (AD169) or VHL/E (VHL/E) at an MOI of
10 (HCMV) compared with uninfected NSC cultures (NI) or with NSCs exposed to UV-irradiated VHL/E HCMV (HCMV-UV) at 72 h pi. This
immunofluorescence analysis is representative of at least ten independent experiments, which gave identical results. Scale bar = 20 μm.
Cyan = DAPI counterstain. (D) Representative enlarged images of immunofluorescence analysis using antibodies specific to LIS1 (red) or IE
(green). Images are maximal-intensity projections of x/y optical section stacks acquired by confocal microscopy, for four different infected
cells. Note the cytoplasmic dot-like pattern of LIS1 immunostaining in HCMV-infected cells compared with non-infected cells (white arrow-
heads). The nucleus groove as seen in the second and fourth cells shown (black arrowheads) is typical of a productively infected cell. Scale
bar = 10 μm. Cyan = DAPI counterstain.
Figure 2. Defective migration ability of HCMV-infected NSCs. (A) Representative cell migration assay (Oris) showing defective migration on a
laminin substrate of NSCs infected at effective MOI (1, 3, 10) compared with uninfected NSCs (NI) or NSCs exposed to UV-irradiated HCMV
(HCMV-UV), or infected with ineffective MOI (0.1). The remaining cell-free area, which is expressed as a percentage of that before infection
(day 0), is shown. At least six identical replicate wells were seeded for each experimental condition and three separate experiments were per-
formed with similar results. (B) Representative views of the exclusion zone in the presence of NSCs labelled by calcein (1 h at 37 C), unin-
fected (NI) or infected (HCMV), at an MOI of 10, at days 0 and 4 pi. (C) Analysis of the growth rates of HCMV-infected or uninfected control
NSC cultures. The number of cells per cm2, as assessed by counting of nuclei after DAPI staining, is shown. NSCs were cultured in triplicate
0.35 cm2 wells and the experiment was performed twice.
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gestational age (23 weeks). All four infected cases pre-
sented (poly)microgyria, which was associated in three
cases with lissencephaly (cases 4752, 4261, 4099), hall-
marks of migration abnormalities [5]. They were associ-
ated with microcephaly (cases 4752, 3955),
ventriculomegaly (cases 4752, 4261, 3955), vascular
lesions (cases 4752, 4099, 3955), and/or intraventricular
(case 4261) or subventricular (case 4099) haemorrhage.
Detailed clinical features of these cases have been
reported elsewhere [11]. There was no familial history
of neurological abnormalities in any of the cases. Fetal
infection by HCMV was evidenced by immunohisto-
pathological analyses of the presence of IE+ cells, as
shown previously [11]. No genetic screen was per-
formed, the aetiology of the disease being infection
by HCMV.
LIS1 was barely detectable in controls, whereas sec-
tions from infected cases showed strongly increased
Figure 3. Increased levels of LIS1 in histological sections from HCMV-infected fetal brains. Representative results of immunohistochemical
staining of brain sections from HCMV-infected fetuses (HCMV) or from controls (NI) using anti-LIS1 or no primary antibody or an isotype
control. The reference number of each sample is indicated on the left of each row. The subventricular zone (SVZ) and the ependymamonolayer
which segregates the SVZ from the ventricular space are shown. Note that cells strongly immunoreactive to anti-LIS1 antibody are detected
in the periventricular areas and in ependyma in infected cases but not in controls. Scale bar = 50 μm.
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LIS1 levels throughout the parenchyma, particularly in
the subventricular zone (SVZ) and the ependyma mono-
layer, which segregates the SVZ from the ventricular
space (Figure 3). Notably, the SVZ is known to host
the neural progenitors/stem cells [24].The validity of
our histological staining was further ensured by staining
of adjacent sections with an isotype control or by omis-
sion of the primary antibody, which were all, as
expected, negative. These findings suggested that LIS1
was upregulated in all cells, infected or not, in utero.
Our observation indicates that PAFAH1B1 expression
is abnormally increased in the brains of congenitally
infected fetuses, thereby strongly supporting its associa-
tion with the pathogenesis of the sequelae of the
infection.
LIS1 is co-expressed and interacts physically with
doublecortin (DCX), another microtubule-associated
protein [25]. Similarly to PAFAH1B1, the gene DCX
has been described as a causative gene for certain forms
of lissencephalies (23%) [26]. In our initial screening,
DCX mRNA levels tended to be increased in HCMV-
infected versus uninfected NSCs (supplementary mate-
rial, Table S1). Therefore, we investigated DCX levels,
both in HCMV-infected NSCs and in the histological
sections from infected cases or controls. We observed
increased levels of DCX in HCMV-infected NSCs com-
pared with the uninfected controls (supplementary mate-
rial, Figure S4). It is noteworthy that DCX staining was
punctate and mostly perinuclear, recalling that of LIS1.
Not all infected NSCs, however, were positive for
DCX. Immunohistochemical analysis was only possible
for cases 3955 and 4752 because of the lack of available
histological material for the other samples. We found
strongly increased immunostaining for DCX throughout
the brains of congenitally infected cases, whereas DCX
expression was hardly detectable in control sections at
this gestational age (Figure 4). These results suggest
widespread overexpression of LIS1 and DCX in the
parenchyma. It is noteworthy that no DCX expression
was detectable for MRC-5 cells, whether infected or
not, by mRNA (supplementary material, Table S2) or
immunofluorescence analyses (not shown).
Discussion
In this study, we report that congenital HCMV infection
is associated with strongly increased expression of
PAFAH1B1/LIS1, both in human NSCs (Figure 1) and
in congenitally infected fetal brains, as early as the
23rd week of gestation (Figure 3) [27].
We observed dramatically increased LIS1 levels in
HCMV-infected NSCs. We previously reported that
infection by HCMV triggered the activity of the nuclear
receptor PPARγ in NSCs [11]. In contrast to that study,
we did not detect any paracrine effect leading to
increased LIS1 levels in the neighbouring uninfected
NSCs. The pattern of LIS1 immunostaining in HCMV-
infected NSCs is suggestive of an association with the
cytoskeleton (Figure 1C,D). This finding is in agreement
with previous studies showing a physical association of
LIS1 with microtubules [28,29]. Moreover, we found
that LIS1 concentrated as puncta, with a size reaching
Figure 4. Increased levels of DCX in histological sections from HCMV-infected fetal brains. Representative results of immunohistochemical
staining of brain sections from HCMV-infected fetuses (HCMV) or from controls (NI) using anti-DCX or no primary antibody or an isotype
control. The reference number of each sample is indicated on the left of each row. Note that cells strongly immunoreactive to anti-DCX anti-
body are detected in the periventricular areas and in ependyma in infected cases but not in controls. Scale bar = 50 μm.
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up to 1.5 μm in diameter (Figure 1C), consistent with
previous observations in COS-7 cells overexpressing
LIS1 [28]. Perinuclear LIS1 immunolabelling observed
in infected NSCs also agrees with previous work show-
ing an association of LIS1 with the Golgi complex [30].
The molecular role of LIS1 has been extensively stud-
ied [19,20]. LIS1 is an adaptor for the microtubule motor
dynein, which it maintains connected to microtubules,
presumably acting as a ‘propeller wheel’ [27]. LIS1 is
critical for cytoskeleton dynamics, nucleokinesis, and
neural cell mobility [21]. Moreover, LIS1 is a down-
stream effector of reelin, a pivotal regulator of neuronal
migration [31], and of platelet-activating factor (PAF),
a lipid mediator regulating neuronal migration and neur-
ite outgrowth [32,33]. LIS1 has been shown to reduce
the rate of transition from growth to shortening of micro-
tubules [29], a dynamic process that could not be
detected in our immunofluorescence assay. Together,
these studies point to LIS1 as a key effector of neural cell
motility. We observed defective migration of HCMV-
infected NSCs in a two-dimension assay, a model that
does not take into account the possible contribution of
glial cells in neural progenitor migration during neurode-
velopment [34,35]. With our study, it is important to
stress that current evidence does not allow us to establish
any formal link between overexpressed LIS1 and altered
migration of HCMV-infected NSCs. Using a lentiviral
transduction strategy, we failed to generate viable NSCs
ectopically expressing LIS1 at a level sufficient to cause
a change in migration abilities. On the other hand, treat-
ment with siRNA targeting LIS1 led to the specific death
of infected NSCs. Therefore, it is not possible to for-
mally conclude that LIS1 plays a role per se in defective
migration of infected NSCs. Depending on the cell con-
text, HCMV infection has been shown to exert opposite
outcomes on cell migration. For instance, HCMV pro-
motes the motility of monocytes through STAT1 activa-
tion [36] and also enhances the migration of arterial
smooth muscle cells through expression of the viral che-
mokine receptor US28 [37]. Conversely, HCMV
impairs the migration of epithelial (cytotrophoblasts)
[16] or endothelial [38] placenta cells through PPARγ
activation or downregulation of angiogenesis genes,
respectively.
We also observed strong immunostaining for LIS1
and DCX in histological sections of cases infected by
HCMV compared with sections from control cases,
which showed no or weak immunostaining (Figures 3
and 4). Key events in neuronal migration occur between
the fifth and 22nd gestational weeks of human develop-
ment [27]. The gestational age (23 weeks) of the four
cases reported herein is consistent with the occurrence
of pathogenic events occurring within this period of
development. To our knowledge, histological analysis
of LIS1 expression during development is not documen-
ted. In contrast, it has been shown that DCX expression
is detectable only within the first 20 gestational weeks in
the human fetal cerebrum [39]. This finding is consistent
with our results, with the absence of DCX immunostain-
ing in the brains of the control cases, also aged
23 gestational weeks. We have previously shown the
immunohistochemical presence of the HCMV antigen
IE in the same cases as the present study [11]. IE+ cells
are localised in a few discrete foci scattered throughout
the brain parenchyma or in vessels. This pattern clearly
does not overlap with that of LIS1 or DCX in the
infected samples. It is, however, still possible that a
non-cell autonomous effect, not detected in cultured
NSCs, underlies increased LIS1 levels in the infected
fetal brain. We had reported PPARγ activation in
HCMV-infected fetal brains [11]. In that study, PPARγ
and IE immunostainings did not overlap in histological
samples. Yet we showed that infected NSCs were able
to trigger PPARγ overexpression in uninfected neigh-
bouring cells by releasing specific activating lipids. It
is therefore likely that LIS1 overexpression might also
be triggered by soluble mediators of unknown origin in
the infected fetal brain. Such a bystander effect could
possibly be of glial origin since it was not detected in
NSC cultures. Because PAFAH1B1 and DCX mutations
are both causative in hereditary disorders of gyration
including lissencephaly, we propose herein that their
dysregulated expression at least contributes to gyration
abnormalities in severe congenital HCMV infection.
Mutational events leading to either haploinsufficiency
or overexpression of PAFAH1B1 are primary causes in
a spectrum of neurodevelopmental disorders. Most
documented are the cases when haploinsufficiency of
PAFAH1B1 causes classic lissencephaly (OMIM
#607432) [40]. However, classic lissencephaly includes
subcortical band heterotopia, which consists of circum-
ferential bands of heterotopic neurons underneath the
cortex. To our knowledge, this feature has never been
reported upon HCMV congenital infection. Conversely,
PAFAH1B1 microduplications are associated with brain
malformations, such as microcephaly or ventriculome-
galy, and cognitive impairment [40,41]. PAFAH1B1
duplications likely result in increased expression
because gene dosage is consistent with copy number
in autosomes [42,43]. Accordingly, increased expres-
sion of PAFAH1B1 mRNA in lymphocytes from a
patient with duplicated PAFAH1B1 has been reported
[41]. A transgenic mouse conditionally overexpres-
sing LIS1 in the developing brain showed a decrease
in brain size and a distorted cellular organisation in
the ventricular zone [41]. Altogether, these findings
underscore that LIS1 dosage must be finely tuned for
proper brain development. A recent study revealed
that mutations within PAFAH1B1 or DCX accounted
for the majority of lissencephaly cases [26]. There-
fore, it is very likely that the unbalanced expression
of PAFAH1B1 andDCX in the HCMV-infected devel-
oping brain underlies brain dysgenesis. Abnormal
neural cell migration was reported to be associated
with cognitive impairment independently of the infec-
tious context [6]. Thus, similar pathogenic events
could possibly underlie mental retardation in mild
cases of congenital HCMV infection.
It is likely that the timing and extent of infection, the
nature of its molecular targets other than PAFAH1B1,
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and the host immune response also modulate the nature
and severity of sequelae.
Given the heterogeneity of the phenotypes due to
duplications of PAFAH1B1, more work is needed to for-
mally correlate LIS1 levels in the developing brain with
the severity of the outcomes of HCMV infection. Indeed,
LIS1 expression levels in the four cases presented here
were not increased to the same extent, with no apparent
relation with the severity of sequelae. An association
study between PAFAH1B1 variants and the severity of
the outcomes of the infection in mildly or severely
affected cases could allow the identification of possible
severity markers. Indeed, HCMV alters gene expression
by subverting the activity of a variety of host transcrip-
tion factors [15,44].We have carried out in silico analysis
of conserved transcription factor binding sites (TFBSs)
within PAFAH1B1. We identified that conserved puta-
tive responsive elements to PPARγ, AP1, and CREB
were located within the 5’ proximal promoter region of
PAFAH1B1, or in its first intron (sequence details avail-
able upon request). Also, a frequent polymorphism
within the 3’ untranslated region of PAFAH1B1 has been
identified [45]. Since PPARγ, AP1, and CREB are trig-
gered by HCMV infection [11,15,44], any hypothetical
variation within these segments could possibly modify
the response of PAFAH1B1 to HCMV infection.
In conclusion, our findings reveal that PAFAH1B1 is a
critical target of congenital HCMV infection and a plau-
sible contributor to the pathogenesis of brain sequelae.
They also shine a new light on the pathophysiological
bases of congenital HCMV infection by suggesting as
well that defective neural cell migration may contribute
to the neurodevelopmental sequelae of infection.
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SUPPLEMENTARY MATERIAL ONLINE
Supplementary figure legends
Figure S1. Immunofluorescence analysis of HCMV-infected (HCMV) or uninfected (NI) NSCs with antibodies to IE (green) or alpha-tubulin (red)
Figure S2. Immunofluorescence analysis of HCMV-infected (HCMV) or uninfected (NI) MRC-5 cells, using antibodies to IE (green) or LIS1 (red)
Figure S3. Ki-67 analysis of NSCs
Figure S4. Immunofluorescence analyses of HCMV-infected (HCMV) or uninfected (NI) NSCs or HIPEC cells, treated with either LIS1-siRNA
(siLIS1) or non-targeting siRNA (siNT)
Figure S5. Immunofluorescence analysis of HCMV-infected (HCMV) or uninfected (NI) NSCs, using antibodies to IE (green) or DCX (red)
Table S1. RT2 profiler analysis of neuronogenesis-related genes in HCMV-infected NSCs
Table S2. RT2 profiler analysis of neuronogenesis-related genes in HCMV-infected MRC-5 cells
Movies S1–S4. 3D reconstructions of immunofluorescence analyses of HCMV-infected NSCs
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